On Publishing Questionable Science

On Publishing Questionable Science Why do I have to make excellent laboratory work to make my papers reviewed (not published) in an average journal (impact of 1.2), whereas Mr. Chapela1 published in Nature a work with so many flaws it wouldn't pass my university's PhD committee? Because he works in a controversial field and obtained results that could put corporations in a bad position. But that is not serious science; that is sensationalism. Millán Cortizo Sabugo Unidad de Fisiolog

Written byCortizo Sabugo
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Why do I have to make excellent laboratory work to make my papers reviewed (not published) in an average journal (impact of 1.2), whereas Mr. Chapela1 published in Nature a work with so many flaws it wouldn't pass my university's PhD committee? Because he works in a controversial field and obtained results that could put corporations in a bad position. But that is not serious science; that is sensationalism.

Millán Cortizo Sabugo
Unidad de Fisiología Vegetal--Dpto. BOS
Universidad de Oviedo, Spain
mcortizo@correo.uniovi.es

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies